Table 3.
Logistic regression output correcting follow-up body composition measures and their distribution between survival and overall mortality and survival and tumor-cause-related mortality.
| Body Composition Measures | Status | Overall Mortality | p-Value * | Tumor-Cause Mortality | p-Value * |
|---|---|---|---|---|---|
| Total area (cm2/m2), mean (SD) | Survival | −0.88 (35.85) | 0.36 | 0.89 (37.01) | 0.44 |
| Mortality | −16.16 (50.37) | −1.90 (19.27) | |||
| Subcutaneous fat area (cm2/m2), mean (SD) | Survival | −0.47 (17.05) | 0.85 | 0.44 (17.75) | 0.32 |
| Mortality | −11.09 (25.49) | −10.46 (14.85) | |||
| Visceral fat area (cm2/m2), mean (SD) | Survival | −0.03 (21.23) | 0.56 | 0.74 (21.47) | 0.44 |
| Mortality | −10.97 (32.19) | −3.75 (20.96) | |||
| Intermuscular fat area (cm2/m2), mean (SD) | Survival | 1.06 (2.36) | 0.74 | 1.13 (2.37) | 0.76 |
| Mortality | 0.76 (2.91) | 1.04 (2.43) | |||
| Total fat area (cm2/m2), mean (SD) | Survival | 0.56 (35.39) | 0.68 | 2.32 (36.5) | 0.37 |
| Mortality | −21.30 (54.02) | −13.17 (30.40) | |||
| VLD muscle area (cm2/m2), mean (SD) | Survival | 0.16 (1.51) | 0.24 | 0.18 (1.50) | 0.10 |
| Mortality | 1.13 (2.41) | 1.63 (2.33) | |||
| LD muscle area (cm2/m2), mean (SD) | Survival | −0.92 (3.60) | 0.02 | −0.83 (3.59) | 0.03 |
| Mortality | 1.22 (3.54) | 1.89 (2.75) | |||
| ND muscle area (cm2/m2), mean (SD) | Survival | −1.61 (5.85) | 0.01 | −1.72 (5.81) | 0.05 |
| Mortality | −4.96 (5.07) | −5.25 (5.11) | |||
| Total muscle area (cm2/m2), mean (SD) | Survival | −2.43 (3.82) | 0.33 | −2.43 (3.77) | 0.72 |
| Mortality | −2.60 (5.72) | −3.15 (6.48) |
Data are presented as mean with standard deviation (SD). VLD, very low-density; LD, low-density; ND, normal density. * Adjusted by: age, metastasis, ECOG (Eastern Cooperative Oncology Group performance status), lactate dehydrogenase (LDH), albumin and urea.